Guest guest Posted August 6, 2003 Report Posted August 6, 2003 Power from blood could lead to 'human batteries' August 4 2003 http://www.smh.com.au/articles/2003/08/03/1059849278131.html A device that produces electricity from blood could be used to turn people into " human batteries " . Researchers in Japan are developing a method of drawing power from blood glucose, mimicking the way the body generates energy from food. Theoretically, it could allow a person to pump out 100 watts - enough to illuminate a light bulb. But that would entail converting all the food eaten by the individual into electricity. In practice, less power would be generated since food is needed by the body. However the scientists say the " bio-nano " generator could be used to run devices embedded in the body, or sugar-fed robots. The team at electronics giant Panasonic's Nanotechnology Research Laboratory near Kyoto has so far only managed to produce very low power levels. But the scientists ultimately expect to gain much greater performance from the device. The battery is based on an enzyme capable of stripping glucose of its electrons, The Engineer magazine reported. Dr Kazuo Eda, heading the research, said: " It is like the metabolism of food. Human bodies can process glucose and obtain energy. When glucose is oxidised, electrons can be obtained. " He believed bio-nano fuel cells were the next step for researchers after generators powered by hydrogen, natural gas and methanol now being developed for the car and energy industries. Unemployed 'more likely to commit suicide' July 30 2003 Unemployed men and women are up to three times more likely to commit suicide than those with jobs, research has revealed. Not being married, having fewer academic qualifications and a lower household income also increased the risk of suicide, according to a report in the latest edition of Journal of Epidemiology and Community Health. Researchers studied more than 2 million people living in New Zealand, basing their findings on the 1991 census, with suicides tracked over the following three years. They found that unemployed men and women aged 25 to 44, and 45 to 64-year-old men were two to three times more likely to kill themselves than their counterparts who had jobs. The authors of the report said the findings held true even when risk factors other than employment - such as income, education and marital status - were taken into account. While the researchers took account of rates of mental illness among the population, the relative risk of mental illness among the unemployed and the attendant risk of suicide, mental illness could be a factor in up to half of the increased risk, the authors said. But they pointed out that the possibility that mental illness explained the link between unemployment and suicide was weakened because most people forced to quit work due to ill health would be classified as non-active, rather than unemployed. The researchers, from the Wellington School of Medicine, suggested that unemployment rates in a society might indicate a lack of social cohesion which in turn was associated with more suicides. PA Alert over taking Prozac during pregnancy August 4 2003 Women who use Prozac and similar anti-depressants during pregnancy and breastfeeding could expose their babies to withdrawal and toxic effects, a federal government drugs watchdog has warned. The Adverse Drug Reactions Advisory Committee says it has received 26 reports of infants with withdrawal symptoms. The effects were attributable to mothers taking the selective serotonin reuptake inhibitor (SSRI) drugs Aropax, Zoloft, Prozac and citalopram. The babies' symptoms included agitation, poor feeding, stomach upsets, convulsions, tremors, fever and respiratory disorders. They began within the first four days of birth and lasted two to three days. There were also 13 reports of adverse effects probably resulting from the transfer of SSRIs from breastmilk to the baby. Many of the symptoms of toxicity were similar to those of withdrawal but in two cases involved babies sleeping for prolonged periods. The watchdog's August bulletin quoted a study published in the Archives of Paediatric Medicine which found that almost one quarter (22 per cent) of newborns who were exposed to paroxetine (marketed in Australia as Aropax) from their mother in the third trimester needed prolonged hospitalisation associated with neonatal complications. The committee recommends the lowest dosage of the drugs be used during pregnancy and that mothers should consider not breastfeeding. " It is probable that neonatal withdrawal effects would be minimised by using the lowest effective maternal dose, " it advises. " Breastmilk transfer can be treated by stopping or reducing the dose of SSRIs or by using formula milk. " AAP More Health & Science Food fur thought: the diet can dye it Alert over taking Prozac during pregnancy Power from blood could lead to 'human batteries' Australian women to trial vaginal gel to fight HIV Kids follow screen idols' smoke trail Scientists explore snoring's wet bed perils Secret women's sickness Decision time looms for junior doctors It's time to get wise to exercise Excessive measures may be justified to beat obesity blues Q & A The good, the bad and the fatty How not to lose it Unemployed 'more likely to commit suicide' Grass pollen blamed for severe asthma outbreaks Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.